Literature DB >> 22514382

Moving towards a universal hepatitis B vaccine program for Canadian children.

N Macdonald1.   

Abstract

Entities:  

Year:  1995        PMID： 22514382      PMCID： PMC3327918          DOI： 10.1155/1995/605787

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN： 1180-2332


× No keyword cloud information.
  6 in total

1.  Hepatitis B in Canada: the case for universal vaccination. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1992-01-01       Impact factor: 8.262

2.  National Advisory Committee on Immunization (NACI) statement on universal immunization against hepatitis B.

Authors:  A O Carter; P Walsh
Journal:  Can Dis Wkly Rep       Date:  1991-08-03

3.  Health care budgets and vaccine programs: a time for review and prioritization.

Authors: 
Journal:  CMAJ       Date:  1994-05-15       Impact factor: 8.262

4.  Hepatitis B Infection in Canada: Epidemiology and implications for control.

Authors:  G Delage; A O Carter
Journal:  Can Fam Physician       Date:  1992-11       Impact factor: 3.275

5.  The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies.

Authors:  M J Alter; S C Hadler; H S Margolis; W J Alexander; P Y Hu; F N Judson; A Mares; J K Miller; L A Moyer
Journal:  JAMA       Date:  1990-03-02       Impact factor: 56.272

6.  A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis.

Authors:  B S Bloom; A L Hillman; A M Fendrick; J S Schwartz
Journal:  Ann Intern Med       Date:  1993-02-15       Impact factor: 25.391
  6 in total
  1 in total

1.  Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada?

Authors:  Urvi Rana; Matt Driedger; Paul Sereda; Shenyi Pan; Erin Ding; Alex Wong; Sharon Walmsley; Marina Klein; Deborah Kelly; Mona Loutfy; Rejean Thomas; Stephen Sanche; Abigail Kroch; Nima Machouf; Marie-Helene Roy-Gagnon; Robert Hogg; Curtis L Cooper
Journal:  BMC Infect Dis       Date:  2019-11-21       Impact factor: 3.090
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.